Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Allan Reine currently holds 775,000 shares of Foghorn Therapeutics Inc. (FHTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Allan Reine has been a net buyer of FHTX stock. They have purchased $313.4K and sold $0 worth of shares.
Allan Reine's most recent insider trade was on Dec 5, 2024, when they sold 75,000 shares at $0.00 per share.
Allan Reine serves as Executive at Foghorn Therapeutics Inc. (FHTX). They have executed 6 insider transactions totaling $313.4K over their tenure at the company.
Allan Reine holds the position of Executive at Foghorn Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Allan Reine has shown a buying trading pattern, with $313.4K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Allan Reine was on Aug 16, 2017, when they purchased $215.6K worth of PIRS shares. This transaction involved 45,000 shares at $4.79 per share.
Allan Reine currently owns 775,000 shares of Foghorn Therapeutics Inc. (FHTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Allan Reine's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Allan Reine has 6 Form 4 filings on record as an insider at Foghorn Therapeutics Inc..
Set alerts for Allan Reine and 40,000+ other insiders.